← Back to Clinical Trials
Recruiting NCT06225648

NCT06225648 Threonine Requirement in Adults >60 Years of Age

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06225648
Status Recruiting
Phase
Sponsor The Hospital for Sick Children
Condition Healthy
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-02-03
Primary Completion 2025-09-30

Trial Parameters

Condition Healthy
Sponsor The Hospital for Sick Children
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 60 Years
Max Age 90 Years
Start Date 2024-02-03
Completion 2025-09-30
All Conditions
Interventions
threonine

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Threonine is an essential amino acid and must be obtained from the diet. The body's capacity to maintain adequate mucin synthesis is directly related to the bioavailability of certain amino acids, including threonine, serine and proline (1). Moreover, the rate of mucin synthesis has been demonstrated to be directly related to the availability of dietary threonine in healthy rats (2) and piglets (3,4). Intestinal inflammation is known to increase gastrointestinal threonine uptake and mucin synthesis in enterally fed minipigs (5). Additionally, in animals, mucin function/barrier has been shown to decline with age, leaving them more susceptible to bacterial penetration. Thus, with advancing age (6), a higher dietary supply of threonine may be needed for maintaining intestinal mucosal health. Despite this, the current threonine requirement is based on studies conducted exclusively in young adults. Thus, there is a need to determine the threonine requirement directly in older adults.

Eligibility Criteria

Inclusion Criteria: * Consent provided * Aged 60 to 90 years old * In good general health as evidenced by medical history, physical health and blood draw * Fasting blood glucose, hemoglobin A1c (HbA1c), urea, creatinine * Willingness to participate in the study. * BMI \<30 kg/m2. Exclusion Criteria: * Presence of chronic disease and/or acute illness known to affect protein/amino acid metabolism (e.g. HIV, diabetes, cancer, liver or kidney disease, acute cold or flu) * Taking medications known to affect protein/AA metabolism (e.g. steroids) * Inability to tolerate the diet (i.e. allergy) * Significant weight loss during the past month or consumption of weight reducing diets. * Significant caffeine consumption (\>2 cups per day) * Significant consumption of alcohol (\>1 drink per day i.e. 1 beer or ½ glass of wine). * Unwilling to have blood drawn from a venous access, or using a ventilated hood indirect calorimeter for the purposes of the study.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology